Fellowships: HIV/AIDS Biological – F21A
Ends after the October 2026 Council round (last expedited submission date of May 7, 2026).
The HIV/AIDS Biological (F21A) study section reviews HIV/AIDS fellowship applications with a biological focus.
This study section operates on an expedited cycle as mandated by Congress and only applications in which there is a clear and compelling HIV/AIDS research component are eligible for review in F21A. Those deemed insufficiently related to HIV/AIDS are assigned to other non-expedited fellowship study sections and must be submitted in time to meet the regular application due dates.
Review Dates
A roster for the panel will be posted here, at least 30 days prior to the review meeting
Topics
- Clinical and epidemiological aspects of HIV/AIDS
- Design, discovery, and development of therapeutics for HIV and AIDS-related diseases
- All aspects of the development of vaccines against HIV and related retroviruses
- Host immune responses to and pathogenesis of HIV and related retroviruses
- Molecular biology, cell biology, structural biology, virology and genetics of HIV and related retroviruses
- Effects of HIV/AIDS on the nervous system and other organ systems
- Biological effects of drug abuse in the context of HIV/AIDS
- Aspects of opportunistic infections in the context of HIV infections and AIDS and cancers associated with HIV and AIDS
Shared Interests and Overlaps
- The HIV/AIDS Behavioral (F18B) study section reviews HIV/AIDS fellowship applications with a behavioral focus.
